Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05657808

Radicle Rest 2: A Study of Health and Wellness Products on Sleep and Health Outcomes

Conditions: Sleep, Sleep Disturbance, Sleep Disorder

Sex: All
Ages: 21 Years – 105 Years
Healthy volunteers: 1
Phase: NA
Enrollment: 300
Sponsor: Radicle Science

Location: United States

Summary

A randomized, blinded, placebo-controlled direct-to-consumer study assessing the impact of health and wellness products on sleep and other health outcomes.

Eligibility Criteria

Inclusion Criteria:Adults, 21 years of age and older at the time of electronic consent, inclusive of all ethnicities, races, genders and/or gender identitiesResides in the United StatesEndorses better sleep as a primary desireSelects sleep, looking to improve their sleep, and/or reduce reliance on medications as a reason for their interest in taking a health and wellness productExpresses a willingness to take a study product and not know the product identity (active or placebo) until the end of the studyExclusion Criteria:Reports being pregnant, trying to become pregnant, or breastfeedingUnable to provide a valid US shipping addressThe calculated validated health survey (PRO) measurement result is less than mild severity/impairmentReports a diagnosis of liver or kidney diseaseReports being a heavy drinker (defined as drinking 3 or more alcoholic beverages per day)Unable to read and understand EnglishReports current enrollment in a clinical trialLack of reliable daily access to the internetReports current or recent (within 3 months) use of chemotherapy, immunotherapy, or oral anti-infectives (antibiotics, antifungals, antivirals) to treat an acute infectionReports taking medications with a known moderate or severe interaction with any of the active ingredients studied: anticoagulants, a medication that warns against grapefruit consumption, corticosteroids at doses greater than 5 mgs per day, or monoamine oxidase inhibitors (MAOIs)Reports a diagnosis of heart disease when a known contraindication exists for any of the active ingredients studied: New York Heart Association (NYHA) Class III or IV congestive heart failure, Atrial fibrillation, Uncontrolled arrhythmias

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05657808). StuddyBuddy aggregates publicly available trial information.